French family man Didier Jembert won a lawsuit against the British concern GlaxoSmithKline, in which he accused the manufacturers of drugs Requip for the treatment of Parkinson's disease that drugs cause an unhealthy craving for same-sex love.
The reason for the sudden change in Jember's sexual preferences was the drug Requip from the British manufacturer GlaxoSmithKline, which the Frenchman took to reduce the symptoms of Parkinson's disease. The drug was addictive.
Jember, 52, has been on medical treatment since 2003, but after two years of medication, he is addicted to online gambling and promiscuous gay parties.
Zhembar tried to commit suicide eight times, because his addictions left him no other choice, and repeatedly spent the entire family budget on gambling.
“These were seven years of war. GlaxoSmithKline lied to us and ruined our lives,”Gembard's wife Cristina said on the steps of a court in Rennes, northwest France.
The French family man managed to sue the company for $ 256 thousand in a lawsuit, after the trial he could not hold back his tears.
The victim's lawyers said that the company for many years, knowing that the pills have unwanted side effects, did not take any action, and only in 2006 put a warning on the packaging.
Gembar stopped taking the drug in 2005 after feeling addicted to their drug effects.
Promotional video:
A court in March after a hearing in the victim's hometown of Nantes ordered GlaxoSmithKline to pay $ 160,000 to Gembert. Then the company appealed against this decision. But a higher court this week not only upheld the compensation, but also raised rates to $ 256,000.